Dec 19,2016

POCTech achieved the first CE certificate of CGMS

Continuous Glucose Monitoring system of POCTech Corporation received first CE certificate, it is a key point for this product to get into European medical market.

REGULATORY CE MARK

#cgm

View Analyst & Ambassador Comments
Go to original news
Jan 26,2015

FDA Approves Dexcom G4 Platinum Continuous Glucose Monitoring System with Share

Dexcom announced today that it has received U.S. Food and Drug Administration (FDA) approval for its Dexcom G4® PLATINUM Continuous Glucose Monitoring System with Share. The Dexcom Share receiver uses a secure wireless connection via Bluetooth Low Energy (BLE) between a patient's receiver and an app on the patient's smartphone to transmit glucose information to apps on the mobile devices of up to five designated recipients, or "followers," without the need for a dedicated docking cradle. These followers can remotely monitor a patient's glucose information and receive alert notifications from almost anywhere, initially via their Apple® iPhone® or iPod® touch and in the future on Android devices, giving them peace of mind and reassurance when they are apart. The "Share" and "Follower" apps will be available on the Apple App Store at no charge.

REGULATORY FDA

#cgm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Apr 03,2015

Artificial pancreas software algorithm receives approval in europe

The Glucositter software algorithm has received a CE Mark in Europe, but the big question is when and how this software will reach patients. Currently, the system runs on a laptop, but a handheld device for patients is an ideal choice. DreaMed Diabetes is the company in charge of commercializing the closed-loop system consisting of software algorithm, pump, and continuous glucose monitoring (CGM).

REGULATORY CE MARK

#closed loop

#cgm

View Analyst & Ambassador Comments
Go to original news
May 06,2015

Senseonics and Rubin Medical to Partner in Scandinavia to Commercialize New CGM Product

Senseonics, Incorporated, a privately held medical device company focused on the development and commercialization of the first fully implantable, long-term continuous glucose monitoring (CGM) system, and Rubin Medical, a market leader in insulin pump distribution, today announced that they’re collaborating to commercialize the new Senseonics® Continuous Glucose Monitoring System in Scandinavia. The collaboration focuses on an exclusive distribution agreement of the Senseonics’ CGM system in Sweden, Norway and Denmark.

COLLABORATION PARTNERSHIP

#product & service

#cgm

View Analyst & Ambassador Comments
Go to original news
Jun 03,2015

Glooko adds Dexcom CGM and Insulet OmniPod

Diabetes management software company Glooko will add its first two continuous glucose monitor and pump integrations into its offering: Dexcom's G4 CGM and Insulet's OmniPod Insulin Management System.

COLLABORATION PARTNERSHIP

#connected device

#cgm

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Jun 05,2015

Medtronic gets major FDA nod

Medtronic has received FDA 510(k) clearance for its MiniMed Connect device, which allows users of Medtronic's continuous glucose monitor (CGM) and insulin pump to view data from those devices on their smartphone. At the same time, Medtronic announced a partnership with Samsung to optimize the viewing of this CGM and pump data.

REGULATORY FDA

#cgm

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Jul 30,2015

Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today announced that it has entered into non-exclusive Development Agreements with Dexcom, Inc. to allow the integration of future generation Tandem insulin pumps with the Dexcom G5 and G6 continuous glucose monitoring ("CGM") systems.

COLLABORATION PARTNERSHIP

#connected device

#cgm

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Aug 14,2015

Next up for Google: a glucose-sensing patch for diabetics

One of the leaders in the diabetes management market is turning to Google to make its blood glucose sensors smaller and more appealing to diabetics. And with some 10 percent of the American population dependent on those sensors to manage their chronic condition, that's a sizeable market to address. San Diego-based Dexcom's partnership with Google's Life Sciences division is designed to create "something that is very, very low cost and very small," Dexcom Vice President Steve Pacelli told Forbes. "Add all that together with a robust data platform. … Diabetes management is largely predicated on having data to make better decisions."

COLLABORATION PARTNERSHIP

#r&d

#cgm

View Analyst & Ambassador Comments
Go to original news
Aug 24,2015

FDA Approves Dexcom G5® Mobile Continuous Glucose Monitoring System

Dexcom announced today that the U.S. Food and Drug Administration (FDA) has approved the Dexcom G5® Mobile Continuous Glucose Monitoring (CGM) System. With wireless Bluetooth® technology built into the device transmitter, the G5 Mobile CGM System is the first and only fully mobile CGM system approved by the FDA for both adults and children as young as 2 years of age that sends glucose data directly to a smartphone, freeing users from the need to carry a separate receiver. The new transmitter securely sends vital glucose information directly to an app on iOS-enabled devices for real-time diabetes management. Android applications will follow early next year. Like its predecessor, the G4 PLATINUM CGM with Share, users can also select up to five designated recipients, or "followers”. These followers can remotely monitor a patient's glucose information and receive alert notifications from almost anywhere.

REGULATORY FDA

#cgm

View Analyst & Ambassador Comments
Go to original news
Sep 29,2015

Medtronic launches smartphone connectivity for CGMs, insulin pumps

Medtronic has launched its MiniMed Connect system, which allows people with diabetes who use both a Medtronic continuous glucose monitor (CGM) and a Medtronic insulin pump to see data from both device on their smartphone, and send it to their caregiver. "It’s part of our plan to become a holistic diabetes management company," Annette Brüls, President of the Diabetes Service and Solutions business at Medtronic, told MobiHealthNews.

PRODUCT

#insulin pump

#cgm

View Analyst & Ambassador Comments
Go to original news
Subscribe to CGM